Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Papillary Thyroid Cancer
83%
Cohort Analysis
71%
Infection
70%
Scatter Factor Receptor
41%
COVID-19
37%
Elective Surgery
32%
Prospective Cohort Study
31%
Overall Survival
23%
Surgery
21%
COVID-19 Vaccination
20%
Head and Neck Cancer
20%
Cetuximab
20%
Subthalamic Nucleus
20%
Progression Free Survival
20%
Thyroglobulin
20%
Retrospective Cohort Study
20%
Parkinson's Disease
20%
Diagnosis
20%
Electrical Brain Stimulation
20%
Population
20%
Clinical Study
20%
Thromboembolism
20%
Anaplastic Thyroid Carcinoma
20%
Nodal Metastasis
20%
Magnetic Resonance Imaging
20%
Recurrent Disease
20%
Lymph Node
20%
Surgical Margin
20%
Heart Surgery
20%
Central Lymph Nodes
20%
Femur Fracture
20%
Health Care Cost
18%
Neoplasm
16%
Disease
16%
Adverse Event
11%
Thyroid Gland
11%
Thyroidectomy
10%
Recurrence Risk
10%
Optimal Drug Dose
9%
Cancer Surgery
8%
Cancer Research
8%
Coloproctology
8%
Anesthesiologist
8%
High Risk Population
7%
Local Recurrence Free Survival
6%
Single Drug Dose
5%
Spectrofluorometry
5%
Odds Ratio
5%
Surgical Mortality
5%
Keyphrases
COVID-19
27%
International Cohort
27%
COVIDSurg
27%
Patient Self-testing
20%
Number Needed to Vaccinate
20%
Receptor Targets
20%
Elective Surgery
20%
Safe Surgery
20%
Surgical Patients
20%
Cardiac Surgery
20%
Central Lymph Node
20%
Papillary Thyroid Cancer
20%
SARS-CoV-2 Vaccination
20%
Early Complications
20%
Prospective Cohort Study
20%
Novel Diagnostics
20%
Nodal Metastasis
20%
Early Outcome
20%
MET Receptor
20%
Fluorescence Spectroscopy
20%
Fluorescence Imaging
20%
Life Data
20%
Diagnostic Tool
20%
Lymph Node Sampling
20%
Sars-cov-2 Infection
20%
Molecular Fluorescence
17%
Cancer Surgery
13%
SARS-CoV-2 Incidence
13%
COVID-19 Mortality
13%
Lead Insertion
13%
Electrophysiology Mapping
7%
Optimal Dose
6%
Analysis Modeling
6%
Local Recurrence-free Survival
6%
Categorical Variables
6%
Sensitivity Analysis
6%
Thyroid Tissue
6%
Normal Thyroid
6%
Metastasis Detection
6%
Type of Surgery
6%
Vaccination
6%
Incidence Rate
6%
Non-cancer
6%
Operation Factors
6%
Surgical Services
6%
Fatality
6%
Thyroid Cancer Recurrence
6%
Multi-diameter
5%
Fluorescence Visualization
5%
Microelectrode Recording
5%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Papillary Carcinoma
41%
Anaplastic Thyroid Carcinoma
41%
SARS Coronavirus
41%
Cohort Study
26%
Thyroglobulin
20%
Cetuximab
20%
Progression Free Survival
20%
Vaccination Policy
20%
Scatter Factor Receptor
20%
Clinical Study
20%
Overall Survival
20%
Head and Neck Cancer
20%
Prospective Cohort Study
20%
Recurrent Disease
20%
Infection
20%
Thromboembolism
20%
Neoplasm
16%
Adverse Event
9%
Disease
8%
Malignant Neoplasm
6%
Local Recurrence Free Survival
6%
Recurrence Risk
5%
Mortality Rate
5%
